Blood stream infections after allogeneic stem cell transplantation: A single-center experience with the use of levofloxacin prophylaxis

Transplant Infectious Disease

Volumn 14, Issue 1, 2012, Pages 40-48

  Busca, A ^a   Cavecchia, I ^b   Locatelli, F ^a   D'Ardia, S ^a   De Rosa, F G ^c   Marmont, F ^a   Ciccone, G ^d   Baldi, I ^d   Serra, R ^a   Gaido, E ^a   Falda, M ^a  

^a AOU San Giovanni Battista   (Italy)

^b SC Pediatria d'Urgenza OIRM/S Anna   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CPO Piemonte   (Italy)

Author keywords

Antibiotic resistance; Bacteremia; Fluoroquinolones; Levofloxacin; Stem cell transplantation

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; LEVOFLOXACIN; PENTAMIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VALGANCICLOVIR;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GUILLERMONDII; CANDIDEMIA; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; ESCHERICHIA COLI; FEMALE; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; PNEUMOCYSTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OFLOXACIN; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84857045142     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00650.x     Document Type: Article

References (19)

1. Ortega M, Rovira M, Almela M, et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005; 84: 40-46.
2. Guthrie KA, Yong M, Frieze D, Corey L, Fredricks DN. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009; 45: 675-681.
3. Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009; 15: 47-53.
4. Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2005; 7: 11-17.
5. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40: 63-70.
6. Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine 1998; 77: 83-101.
7. Bucaneve G, Castagnola E, Viscoli C, Leibovici L, Menichetti F. Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients. Eur J Cancer 2007; 2(Suppl 5): 5-12.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 19th Informational Supplement. Wayne, PA: CLSI, 2009.
9. Fine JP, Gray RJ.A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
10. Meyer E, Beyersmann J, Bertz H, et al. Risk factors analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 2007; 39: 173-178.
11. Collin B, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947-953.
12. Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41-47.
13. Orasch C, Weisser M, Mertz D, et al. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2010; 45: 521-526.
14. Gratwohl A, Brand R, Frassoni F, et al. Causes of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005; 36: 757-769.
15. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41: 1254-1260.
16. Reuter S, Kern WV, Sigge A, et al. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 2005; 40: 1094-1095.
17. Parody R, Martino R, Rovira R, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734-748.
18. Narimatsu H, Matsumura T, Kami M, et al. Bloodstream infections after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005; 11: 429-436.
19. Craig M, Cumpston AD, Hobbs GR, DeVetten MP, Sarwari AR, Ericson SG. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in hematological malignancy and transplantation unit. Bone Marrow Transplant 2007; 39: 477-482.